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INTRODUCTION 
Otorrhoea commonly hits young people. Risk factors of 
otitis occurrence as described by literature, are the 
presence of smokers among patients [1,2], chronic 
otorrhoea over twelve months and the number of 
children living on the same roof [3].  Ciprofloxacin and 
rifampicin are the two ear drop antibiotics commonly 
used for the probabilistic treatment of otitis in 
Madagascar. Discharge in the ear known as otorrhoea is 
a common reason for medical consultation. Otitis media 
is an infectious disease widely found around the world. 
In the United States, it represented 42% of antibiotic 
treatment prescribed in ambulatory [4].  
The change of behaviour of these pathogens because of 
antibiotics should lead to new reflexions on how therapy 
must be conducted [5]. Identifying bacteria involved in 
otitis media is a prerequisite for possible drugs to be 
tested to deal with otitis media and later, to do an 
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effective probabilistic antibiotic therapy. This study 
aimed to determine the potentially dangerous bacteria 
involved in otitis and to identify their resistance to 
fluoroquinolone or rifampicin. 
MATERIAL AND METHODOLOGY    
Study design: Prospective descriptive study  
Ethics approval and informed consent: Informed 
consent was obtained from participants  
Time frame: May 2016 to February 2017 
Study location: at the laboratory of UHC PZaGa in 
Mahajanga (Madagascar) with the collaboration of the 
Ear Nose and Throat unit (ENT) 
Inclusion criteria: Including all patients with otorrhoea 
who accepted to undergo consultation at the ENT unit.  
Exclusion criteria: Who are on or past same antibiotic 
therapy  
Sample size: Fifty-six  
Sample collection: Samplings were performed by 
aspirating the auditory canal using 2ml sterile syringe; 
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samples were then headed to the laboratory in less than 
30 minutes and immediately tested. 
Method: A questionnaire was established and 
completed for each patient at the ENT unit for 
demographic data. The samples of otorrhoea were 
collected and sent for following examination at the 
laboratory where culture media were used: chocolate 
agar plate, Hektoen agar which is a selective media for 
Gram-negative rods, Uriselect chromogenic agar to 
identify bacteria using colour, Mueller Hinton for the 
antibiogram. Sensitivity test drugs used were 
Ciprofloxacin (5µg charge disc, Oxoid, Grande 
Bretagne) and Rifampicin disc (5µg charge disc, Oxoid, 
Grande Bretagne). 
Day 1: Direct examination, sample inoculation on 
culture media and incubating at 37°C for 24h;  
Day 2: Identification and antibiogram, re-isolation if 
needed; 
Day 3-4: Reading of the antibiogram and results. 
RESULTS  
In whole, 56 patients were included with a sex ratio of 
0,93 (p>0,05). The mean age was 14.74 years old, age 
range from 2 to 10 years old was predominant (37,5%), 
followed by individuals aged between 11 to 20 years 
(21.4%) then 21 to 30 years (21.4%) (p>0,05). Smokers 
represented 46.4% (n=26 ; p>0,05). Patients from urban 
area were 53.6% (n=30 ; p>0,05). In descending order, 
the number of children living on the same roof from 1 to 
2 years old was 37,5%, those of 3 to 4 (35,7%), and of 5 
or above (26,8%). As for the level of education of 
parents, 44,6% with primary education, 25% with 
secondary education, 16,2% university and 7,1% 
illiterates (p>0,05). Chronic otitis media (COM) were 
the predominant (82,2%, n=46), then AOM (acute otitis 
media) (8,9%, n=5) and otitis externa (8,9%, n=5). 
Amidst identified microorganisms were fungus (4,7%) 
and bacteria (95,3%) to which Gram-negative rods 
72,1% (n=44), Gram-positive cocci 6,4% (n=10), Gram-
positive bacilli 8,2% (n=5) and Gram négative cocci 
3,3% (n=2). Among these bacteria, Pseudomonas 
aeruginosa and Proteus sp were predominant, with 
respectively 41% (n=25), 23% (n=14). However, three 
cases of otorrhoea with S. aureus were reported, six 
with negative coagulase Staphylococcus, one with 
Escherichia coli, one with Klebsiella sp, one with 
Haemophilus sp, two cases with Neisseria sp and four 
cases with Corynebacterium sp. Two cultures were 
noticed, one of them monomorphic (91,1%, n=51) and 
the other polymorphic (8,9%, n=5) to which three 
associations of P. aeruginosa-Proteus sp, one 
association of P. aeruginosa- coagulase-negative 
Staphylococcus and 1 association of P. aeruginosa- E. 
coli. No resistance to ciprofloxacin was observed with 
Pseudomonas, Neisseria sp, Haemophilus sp, and 
Enterobacter sp except for E. coli. No resistance to 
rifampicin was observed with S. aureus. However, the 
sensitivity of S. aureus to ciprofloxacin decreased (one 
case of three).  
Table 1: Bacteria identified  
Table 2: Ciprofloxacin sensitivity  
Table 3: Rifampicin sensitivity  
Table 4 : Otorrhoea origin  
DISCUSSION  
Otorrhoea is a medical condition with a common reason 
for ENT consultation. Results showed that there is no 
significant association between gender and the occurrence 
of otorrhoea. Authors, in Italia, reported a similar result in 
which female gender represented 55,6% [6]. The bacteria 
involvement is predominant with a monomorphic culture; 
the association of most pathogenic bacteria is also 
reported by other authors [7,8]. Pseudomonas aeruginosa 
that colonise the ears is predominant (Table I). It is the 
case found by other authors in Niger [9] but in South 
Africa, it comes in the second position after Proteus sp 
[10]. 
As for otitis externa, the common bacteria were 
Pseudomonas aeruginosa, enterobacteria, 
Int. j. clin. biomed. res. 2020;6(1):25-28. 
Germe N 
Pseudomonas aeruginosa 25 (41) 
Haemophilus sp 1 (1.6) 
Escherichia coli 1 (1.6) 
Proteus sp 14 (23) 
Corynebacterium sp 4 (6.7) 
Staphylococcus aureus 3 (4.9) 
Negative coagulase Stapylococcus 6 (9.8) 
Enterobacter sp. 2 (3.3) 
Streptococcus sp. 1 (1.6) 
Nesseria sp 2 (3.3) 
Klebsiella sp 1 (1.6) 
Positive Gram Bacillis unidentifiables 1 (1.6) 
Bacteria 
Ciprofloxacin test 
Sensible Résistant 
N (%) N (%) 
Pseudomonas aeruginosa 25 (100) 0 
Proteus sp 14 (100) 0 
Staphylococcus aureus 1 (33) 2 (67) 
Escherichia coli 0 1 (100) 
Enterobacter sp 2 (100) 0 
Klebsiella sp 1 (100) 0 
Nesseria sp 2 (100) 0 
Haemophilus sp 1 (100) 0 
Bacteria 
Rifampicin test 
Sensible Résistant 
N (%) N (%) 
Staphylococcus 
aureus 
3 (100) 0 
Otitis N (%) 
Otitis externa 5 (8.9) 
Acute otiti media 5 (8.9) 
Chronic otitis media 46 (82.2) 
Total 56 (100) 
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Staphylococcus aureus and Streptococcus pyogenes. 
The pool of bacteria reported in the study is similar to 
the results, but as noted, the predominance of 
Pseudomonas aeruginosa as causative organisms of 
otitis externa varies according to studies [11]. In the US, 
authors reported 37,7% of  Pseudomonas aeruginosa 
[12]. 
For acute otitis media, we found 60% of Pseudomonas 
aeruginosa. Which is not the case in France, where 
Husson reported 4,7% [13]. In France, Haemophilus 
influenza is the first causative agent of acute otitis 
media, followed by Streptococcus pneumoniae. AOM is 
very common, and at least 75 % of children have 
contracted it before starting school [14]. 
For the chronic otitis media, a predominance of 
Pseudomonas aeruginosa and Proteus sp. was found 
with respectively 40% and 26%. In India, Tanmoy D. 
and Debabrata R., reported in 2012, 37% of 
Pseudomonas aeruginosa and 17% of Proteus [15]. But 
in Mali, the prevalence of proteus (34,79%) is much 
higher than that of Pseudomonas (4,35%) as reported by 
a study in 2014[16]. Fluoroquinolone represents the 
topical treatment of this condition because of its broad 
antimicrobial spectrum, a well-suited action against 
more colonising strains and due to its lack of otitis 
related toxicity [17]. 
The fungal organisms of otitis are not to be excluded. 
Causative agents of otitis mycosis belong exclusively to 
the genus Aspergillus and Candida. The frequently 
encountered germ in Europe is Candida albicans, 
followed by Aspergillus niger and Aspergillus flavus. 
Regarding the use of ciprofloxacin, all bacteria of 
Pseudomonas aeruginosa were sensitive to the 
antibiotic. It is also the case in South Africa [9]. But in 
other countries like Pakistan, sensitivity is reduced, 
70,8% in 2012 [18] and of 37,7% in Nigeria in 2010 
[19]. The sensitivity of S. aureus to ciprofloxacin 
decreased. This phenomenon is due to the gene 
mutation of the bacteria. The use of a sole therapy of 
ciprofloxacin enhances the gene mutation favourably. In 
2015, the sensitivity of otitis S. aureus found in India 
was 29,41% [20]. On the opposite, rifampicin remained 
the topical drug to treat otitis in the case of S. aureus for 
Madagascar. No resistance was found during the study. 
As for enterobacteria or pseudomonas, rifampicin is 
naturally resistant to but ciprofloxacin remains the 
effective antibiotic for Gram-negative bacillus in case of 
otitis in Madagascar. Throughout the study, the 
identification of the otitis associated bacteria is used to 
guide the anti biotherapy even if the antibiogram fails to 
come. 
CONCLUSION  
In Mahajanga, the most pathogenic bacteria of otorrhoea 
were primarily Pseudomonas aeruginosa and Proteus 
sp, but fungal involvement is not to be excluded. 
Indeed, the use of rifampicin or fluoroquinolone must 
follow indication depending on the type and origin of 
otitis, knowing that the bacteria mutation and the 
resistance rate of these bacteria to these antibiotics. 
Rifampicin ear drop in ambulatory treatment is not 
advised until S. aureus is being identified.  
Clinical use of study: Though the size of the sample is 
limited, these results reflect the benefit of 
microbiological screening of otorrhoea. 
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